MMP-13 Substrate (TFA)
MMP-13 Substrate TFA is a substrate of MMP-13. MMP-13 Substrate TFA can be used for the research of osteoarthritis (OA) [1].
Product Specifications
UNSPSC
12352209
Target
MMP
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mmp-13-substrate-tfa.html
Smiles
O=C(O)C(F)(F)F.CC(C)C[C@@H](C(N)=O)NC(CNC([C@H](CCCNC(N)=N)NC([C@H](CCSC)NC(CNC([C@H](CC(C)C)NC([C@H]1N(C(CNC2=CC=C([N+]([O-])=O)C=C2[N+]([O-])=O)=O)CCC1)=O)=O)=O)=O)=O)=O.[x]
Molecular Formula
C40H64N14O12S.xCF3COOH
Molecular Weight
965.09 (free base)
References & Citations
[1]Hu Q, Ecker M. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. Int J Mol Sci. 2021 Feb 9;22 (4) :1742.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1071120-01 0.02 mg (E-Coli)
Recombinant Xylella fastidiosa NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details MBS1071120-02 0.1 mg (E-Coli)
Recombinant Xylella fastidiosa NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details MBS1071120-03 0.02 mg (Yeast)
Recombinant Xylella fastidiosa NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details